ChatGPT performs well in answering genetic testing questions
Mar 22, 2024
ChatGPT performance was equally accurate for fact-based and counseling-type questions regarding gynecologic cancers.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
Ultraprocessed foods increase risk for broad range of poor health outcomes
Mar 07, 2024
The findings were seen across cardiometabolic common mental disorder and mortality outcomes.
2023 to 2024 seasonal influenza vaccine effective for reducing risk
Feb 29, 2024
Vaccine effectiveness against influenza-linked outpatient visits ranged from 33 to 49%, and against hospitalization it ranged from 41 to 44% among adults.
Cannabis use linked to adverse cardiovascular outcomes
Feb 28, 2024
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
Treatment for cannabis use disorder has decreased since 2004
Feb 27, 2024
For people with cannabis use disorder in 2004 to 2014, specialty treatment decreased in states with medical cannabis laws with dispensary provisions.
Electric bike injuries, hospitalizations increased significantly in recent years
Feb 23, 2024
The incidence of head injuries has outpaced e-bike injuries overall.
Percentage of Mycoplasma pneumoniae infections up since September 2023
Feb 22, 2024
A decrease was seen in the percentage of M. pneumoniae-related diagnoses during the pandemic period, followed by a postpandemic increase.
Incidence of fatigue, chronic fatigue increased significantly after COVID-19 infection
Feb 21, 2024
An increased risk was seen for fatigue and chronic fatigue, with hazard ratios of 1.68 and 4.32 compared with non-COVID-19 controls.